Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 295

1.

Risk of venous thromboembolism with third-generation oral contraceptives: A review.

Weiss G.

Am J Obstet Gynecol. 1999 Feb;180(2 Pt 2):295-301.

PMID:
9988833
2.
3.

The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.

Lewis MA, Heinemann LA, MacRae KD, Bruppacher R, Spitzer WO.

Contraception. 1996 Jul;54(1):5-13. Erratum in: Contraception 1996 Aug;54(2):121.

PMID:
8804801
6.

Modern oral contraceptives and cardiovascular disease.

Rosenberg L, Palmer JR, Sands MI, Grimes D, Bergman U, Daling J, Mills A.

Am J Obstet Gynecol. 1997 Sep;177(3):707-15. Review.

PMID:
9322646
7.

Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10 years after the third-generation "pill scare".

Heinemann LA, Dinger JC, Assmann A, Minh TD.

Contraception. 2010 May;81(5):401-7. doi: 10.1016/j.contraception.2009.12.014. Epub 2010 Jan 27.

PMID:
20399946
8.

[Third-generation oral contraceptives--how big is the risk of venous thrombosis?].

Iversen OE.

Tidsskr Nor Laegeforen. 2004 Jun 3;124(11):1521-2. Review. Norwegian. No abstract available.

9.

The differential risk of oral contraceptives: the impact of full exposure history.

Lewis MA, MacRae KD, Kühl-Habichl D, Bruppacher R, Heinemann LA, Spitzer WO.

Hum Reprod. 1999 Jun;14(6):1493-9.

PMID:
10359554
10.

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.

Rosing J, Middeldorp S, Curvers J, Christella M, Thomassen LG, Nicolaes GA, Meijers JC, Bouma BN, Büller HR, Prins MH, Tans G.

Lancet. 1999 Dec 11;354(9195):2036-40.

PMID:
10636369
11.

Oral contraceptives, thrombosis and haemostasis.

Rosing J, Curvers J, Tans G.

Eur J Obstet Gynecol Reprod Biol. 2001 Apr;95(2):193-7. Review.

PMID:
11301170
12.

[Changed routines in connection with first prescription of oral contraceptives. Lower risk of venous thromboembolism with levonorgestrel preparations].

Milsom I, Odlind V, von Schoultz B, Ostlund I, Persson E.

Lakartidningen. 2002 Jan 10;99(1-2):10-2, 15. Swedish. No abstract available.

PMID:
11871161
13.

The truth about oral contraceptives and venous thromboembolism.

Shulman LP, Goldzieher JW.

J Reprod Med. 2003 Nov;48(11 Suppl):930-8. Review.

PMID:
14686030
14.

Effect of oral contraceptive progestins on serum copper concentration.

Berg G, Kohlmeier L, Brenner H.

Eur J Clin Nutr. 1998 Oct;52(10):711-5.

PMID:
9805216
15.
16.

Oral contraceptives and venous thromboembolism: an epidemiological review.

Lidegaard O.

Eur J Contracept Reprod Health Care. 1996 Mar-May;1(1):13-20. Review.

PMID:
9678133
17.
18.

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.

Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Büller HR, Vandenbroucke JP.

Lancet. 1995 Dec 16;346(8990):1593-6.

PMID:
7500751
19.

Oral contraceptives and venous thromboembolism: which are the safest preparations available?

Girolami A, Spiezia L, Rossi F, Zanon E.

Clin Appl Thromb Hemost. 2002 Apr;8(2):157-62. Review.

PMID:
12121057
20.

Smoking and use of oral contraceptives: impact on thrombotic diseases.

Lidegaard O.

Am J Obstet Gynecol. 1999 Jun;180(6 Pt 2):S357-63.

PMID:
10368521

Supplemental Content

Support Center